Kyntra Bio (KYNB) Research & Development (2014 - 2026)

Kyntra Bio has disclosed Research & Development across 13 years of filings, most recently posting $6.8 million for Q2 2026.

• In Q2 2026, Research & Development rose 16.3% year-over-year to $6.8 million; the TTM figure through Jun 2026 stood at $22.9 million (down 45.41% YoY), while the FY2025 annual figure was $23.5 million, down 75.42% from the prior year.
• Research & Development came in at $6.8 million for Q2 2026 at Kyntra Bio, down from $7.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $95.5 million in Q2 2023 to a low of $1.2 million in Q3 2025.
• Average Research & Development over 5 years is $38.7 million, with a median of $33.8 million recorded in 2023.
• Year-over-year, Research & Development soared 34.55% in 2023 and tumbled 93.95% in 2025.
• Over 5 years, Research & Development stood at $61.6 million in 2022, then plunged by 42.7% to $35.3 million in 2023, then slumped by 80.55% to $6.9 million in 2024, then gained by 5.82% to $7.3 million in 2025, then dropped by 6.15% to $6.8 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $6.8 million in Q2 2026, $7.6 million in Q1 2026, and $7.3 million in Q4 2025.